Posted on 2/10/20
CitiusTech Announces Partnership with Google Cloud
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, today announced a partnership with Google Cloud to accelerate digital transformation and cloud adoption . . .
Posted on 2/7/20
Bristol-Myers Squibb's Earnings Get a Boost From Celgene Acquisition
Fourth-quarter revenue at Bristol-Myers Squibb (NYSE:BMY) jumped 33% year over year thanks to its purchase of Celgene, which closed in the latter half of November. On . . .
Posted on 2/7/20
Cigna's Express Scripts Acquisition Continues to Pay Off With Its Q4 Earnings Beat
Cigna Corporation (NYSE:CI) took investors on a wild ride in 2019. The stock plunged more than 20%, only to make a big comeback toward the end . . .
Posted on 2/7/20
What's Behind Regeneron Pharmaceuticals' Great Q4 Results
Sure, Regeneron Pharmaceuticals' (NASDAQ:REGN) stock performance in 2019 was anemic. And, yes, heading into its fourth-quarter update the biotech hadn't excited investors so far in 2020.But . . .
Posted on 2/7/20
Regeneron Shares Rise on Earnings, Coronavirus Work
Regeneron Pharmaceuticals (NASDAQ:REGN) reported fourth-quarter results that beat expectations, and investors -- who have been snapping up the stock this week based on news that it's . . .
Posted on 2/7/20
Is Merck's Decision to Slim Down a Buying Opportunity?
On Wednesday, the multinational pharmaceutical giant Merck (NYSE:MRK) revealed plans to carve out its women's health, legacy brands, and biosimilars units into a stand-alone business. This . . .
Posted on 2/7/20
Here's Why Cognizant Stock Jumped 10% Today
What happenedShares of Cognizant Technology Solutions (NASDAQ:CTSH) rose 9.9% on Thursday, boosted by a strong earnings report.So whatThe massive provider of IT services and consulting programs . . .
Posted on 2/7/20
Johnson & Johnson Hit With $750 Million Fine Over Baby Powder Legal Case
On Thursday afternoon, news broke that a New Jersey state jury had ordered Johnson & Johnson (NYSE:JNJ) to pay $750 million in punitive damages to four . . .
Posted on 2/7/20
GlaxoSmithKline Cutting Up to 720 Jobs at European Vaccine Facility
In advance of its split into two companies, pharmaceutical giant GlaxoSmithKline (NYSE:GSK) announced it will cut as many as 720 workers from its vaccine production facility . . .
Posted on 2/6/20
DisposeRx Partners with Garden State Pharmacy Owners
DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, and Garden State Pharmacy Owners (GSPO), the association of New Jersey independent pharmacies, have entered . . .
Posted on 2/6/20
Better Coronavirus Play: Johnson & Johnson vs. Novavax
Fears about the coronavirus outbreak that first hit China are increasing. There have been more than 20,000 confirmed cases of the virus and 425 deaths in . . .
Posted on 2/6/20
3 Reasons It's Not Too Late to Buy Teladoc Health
You can be too late to the party with some stocks. Sometimes investors buy a stock after it's delivered massive returns only to find that the . . .
Posted on 2/6/20
GlaxoSmithKline Predicts a 2020 Loss, Prepares for Its Consumer Spinoff
GlaxoSmithKline (NYSE:GSK) reported fourth-quarter earnings results Wednesday, along with guidance for 2020 that was less than encouraging. But investors' disappointment with outlook may have been tempered . . .
Posted on 2/6/20
The 4 Most Important Things to Know About Merck's Q4 Earnings Results
Merck (NYSE:MRK) is off to a rocky start in 2020. The company's blockbuster cancer drug, Keytruda, disappointed in a late-stage clinical study targeting small cell lung . . .
Posted on 2/6/20
Merck Announces a Big Planned Spinoff
Merck (NYSE:MRK) announced Wednesday its intention to spin off its women's health business, legacy brands, and biosimilars unit into an independent, publicly traded company, and reorient . . .
Posted on 2/6/20
Catalent Makes $315 Million Acquisition in Cellular Medicine
First it was gene therapy. Now, drug manufacturer Catalent (NYSE:CTLT) is moving into cellular medicines.The company paired the announcement of fiscal second-quarter 2020 operating results with . . .
Posted on 2/5/20
Foley Hoag Represents Biogen in $1 Billion Credit Facility
Foley Hoag LLP advised Biogen Inc. (Nasdaq: BIIB), a global biotechnology company, in connection with its $1.0 billion senior unsecured revolving credit facility. Biogen entered the . . .
Posted on 2/5/20
Bristol-Myers: Buy At The Highs
SummaryBristol-Myers closed the Celgene acquisition back in November proving an immediate 40% accretion to BMY earnings.Investors should watch for 2020 guidance to top $6.20 EPS estimates . . .
Posted on 2/5/20
Bristol-Myers Squibb and BioMotiv Launch Fibrosis Specialist Anteros Pharmaceuticals
Bristol-Myers Squibb (NYSE:BMY) and drug development accelerator BioMotiv have launched Anteros Pharmaceuticals, a biotech company focused on developing drugs for fibrotic and other inflammatory diseases. The . . .
Posted on 2/4/20
Merck's Insomnia Drug Approved for Alzheimer's Patients
Merck (NYSE:MRK) received approval from the U.S. Food and Drug Administration to market its insomnia drug Belsomra (suvorexant) for treating sleep disruption in patients with mild-to-moderate . . .
Posted on 2/4/20
PRISM Vision Group Announces Affiliation with The Retina Care Center
UNION, N.J.--(BUSINESS WIRE)--PRISM Vision Group™, the largest independent ophthalmology administrative services organization in the region, announces its affiliation with The Retina Care Center, a practice comprised . . .
Posted on 2/4/20
CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits
BERKELEY HEIGHTS, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 2/3/20
Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers (SHL.DE) announced today that it was selected by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to be . . .
Posted on 2/3/20
New England Bioassay Spins Out From GZA as New, Independent Firm
New England Bioassay Inc. (NEB), a leading provider of ecological and wastewater-toxicity testing, has reached an agreement to spin out from longtime owner GZA GeoEnvironmental Inc.
Posted on 2/3/20
Biotech Bankruptcies Hit Recent High in 2019
Biotech investors might have had an exciting year in 2019 with an impressive amount of new drug approvals. There were 14 notable bankruptcies last year as . . .
New York
